EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 101 | -35.7% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 157 | -30.8% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 227 | -6.6% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 243 | +21.5% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 200 | -5.7% | 0.00% | – |
| Q2 2021 | $13,000 | -27.8% | 212 | +6.0% | 0.00% | – |
| Q1 2021 | $18,000 | -74.6% | 200 | -75.0% | 0.00% | -100.0% |
| Q4 2020 | $71,000 | -24.5% | 800 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $94,000 | +23.7% | 919 | -4.6% | 0.00% | 0.0% |
| Q2 2020 | $76,000 | +192.3% | 963 | +112.6% | 0.00% | – |
| Q1 2020 | $26,000 | +136.4% | 453 | +112.7% | 0.00% | – |
| Q4 2019 | $11,000 | 0.0% | 213 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | 0.0% | 213 | -6.2% | 0.00% | – |
| Q2 2019 | $11,000 | -38.9% | 227 | -37.5% | 0.00% | – |
| Q1 2019 | $18,000 | – | 363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |